Longevity Isn’t “More Antioxidants”, It’s Better Cellular Budgeting
Aging accelerates when growth signals stay high and cleanup signals stay low. mTOR and ROS are not villains, they are dials that need the right setting for the moment.
Why it matters: Chronic mTORC1 activation pushes cells toward growth and away from autophagy, the recycling program that clears damaged proteins and organelles. Chronic oxidative stress happens when ROS production outpaces antioxidant defenses, driving molecular damage and dysfunctional signaling. The surprising angle is that both systems are adaptive in short bursts, but costly when stuck “on.”
The evidence:
- A highly cited 2023 review in Signal Transduction and Targeted Therapy (Panwar et al.) describes mTOR as a master regulator of metabolism, immune function, and autophagy, with two complexes (mTORC1/2) that coordinate growth and repair. https://doi.org/10.1038/s41392-023-01608-z
- Two 2023 reviews synthesize how ROS act as normal signaling molecules, but excess ROS relative to endogenous defenses (SOD, catalase, GPx) drives oxidative stress linked to metabolic disease, cancer, and neurodegeneration (Afzal et al., Frontiers in Pharmacology; Rauf et al., Food Science & Nutrition). https://doi.org/10.3389/fphar.2023.1269581 and https://doi.org/10.1002/fsn3.3784
- A 2024 Nature Aging study (Chen et al.) found small extracellular vesicles (sEVs) from young plasma improved mitochondrial energy metabolism and reversed functional declines in aged mice, consistent with the idea that aging is partly a failure of cellular communication and mitochondrial control. https://doi.org/10.1038/s43587-024-00612-4
What to do:
- Build a weekly rhythm that alternates growth and cleanup: prioritize resistance training and protein at some meals, then include periods that favor autophagy and mitochondrial stress adaptation (sleep consistency, aerobic work, and occasional longer gaps between dinner and breakfast).
- Treat “antioxidants” as a food pattern, not a pill category: emphasize whole foods that support endogenous defense systems, plus behaviors that reduce ROS overflow (cardiorespiratory fitness, glycemic stability, and avoiding chronic sleep debt).
The counterpoint: Mouse rejuvenation via young-plasma sEVs is mechanistically exciting but not a ready human protocol, and bluntly suppressing ROS can backfire by blocking beneficial training and stress-adaptation signals.